Tang Rui, Han Dongdong, Li Modan, Shen Shan, Huang Xin, Zhao Wenping, Dong Jiahong
Department of Hepatopancreatobiliary Surgery, Beijing Tsinghua Changgung Hospital, Medical Center, Tsinghua University, Beijing, China.
Department of Oncology, Beijing Tsinghua Changgung Hospital, Medical Center, Tsinghua University, Beijing, China.
ANZ J Surg. 2017 Oct;87(10):767-772. doi: 10.1111/ans.14044. Epub 2017 Aug 29.
Adequate hepatopetal portal vein blood flow is obligatory to ensure proper liver function after liver transplantation. Large collateral veins as shunts impair portal vein flow and even cause hepatofugal blood flow and portal steal syndrome. In particular, splenorenal shunts in liver transplant recipients can lead to allograft dysfunction and possible allograft loss or hepatic encephalopathy. Restoration of portal flow through left renal vein ligation (LRVL) is a treatment option, which is much easier compared to splenectomy, renoportal anastomosis and shunt closure, but bears the risk of moderate and temporary impairment of renal function. In addition, a patent portal vein is mandatory for LRVL. However, although LRVL has been reported to be an effective, safe and easy method to control portacaval shunts and increase hepatopetal flow in some studies, indications and safety are still not clear. In this review, we summarize existing studies on LRVL during liver transplantation.
充足的向肝门静脉血流对于确保肝移植后肝脏功能正常至关重要。作为分流的大侧支静脉会损害门静脉血流,甚至导致离肝血流和门静脉盗血综合征。特别是,肝移植受者的脾肾分流可导致移植物功能障碍以及可能的移植物丢失或肝性脑病。通过结扎左肾静脉(LRVL)恢复门静脉血流是一种治疗选择,与脾切除术、肾门静脉吻合术和分流闭合术相比,它要容易得多,但存在肾功能中度和暂时受损的风险。此外,LRVL要求门静脉通畅。然而,尽管在一些研究中已报道LRVL是控制门腔分流和增加向肝血流的有效、安全且简便的方法,但其适应证和安全性仍不明确。在本综述中,我们总结了肝移植期间LRVL的现有研究。